Telegraph investigation finds ‘critical’ information missing from early warnings about AstraZeneca vaccine’s side effects ...

AstraZeneca’s manufacturing will-they-won’t-they within its home country has swung back firmly toward the "they won’t" camp ...

AstraZeneca scrapped plans for a £450 million UK vaccine plant after rejecting a £78 million government offer, citing ...

The boss of drugmaker AstraZeneca has said he was ‘very disappointed’ with the firm’s move to scrap plans for a £450 million vaccine plant in Liverpool, but insisted the business case did ...

AstraZeneca have not stated plans for an alternative. An FT report meanwhile said that vaccines were “off strategy” for AstraZeneca, suggesting “figures on both sides of the negotiations hav ...

AstraZeneca's chief, Pascal Soriot, has said he is "very disappointed" after scapping plans for a £450m vaccine plant in Liverpool, but stressed that the numbers just didn't add up. The CEO of ...

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune ... right patient, right safety and right commercial. ‘Right patient’, for example, is about finding the patient ...

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

LONDON, Jan 31 (Reuters) - AstraZeneca (AZN.L), opens new tab on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...